No CrossRef data available.
The NIH Consensus Development Program: The Evolution of Guidelines
Published online by Cambridge University Press: 10 March 2009
Abstract
The U.S. National Institutes of Health (NIH) Consensus Development Program (CDP) Guidelines have undergone some modifications over the program's 18-year history. They have never been published in archival form. This article reviews the evolution of the NIH CDP Guidelines and then presents the complete 1995 version.
- Type
- General Essays
- Information
- International Journal of Technology Assessment in Health Care , Volume 12 , Issue 3 , Summer 1996 , pp. 460 - 474
- Copyright
- Copyright © Cambridge University Press 1996
References
REFERENCES
1.Ferguson, J. H.NIH consensus conferences: Dissemination and impact. Annals of the New York Academy of Sciences, 1993, 703, 180–99.CrossRefGoogle ScholarPubMed
2.Ferguson, J. H.Patient participation in medical consensus conferences. Annals of Oncology, 1995, 6(supp. 2), s3–4.Google Scholar
3.Ferguson, J. H.The NIH consensus development program. Joint Commission Journal on Quality Improvement, 1995, 21, 332–36.Google Scholar
4.Goodman, C., & Baratz, S. R., eds. Improving consensus development for health technology assessment: An international perspective. Washington, DC: National Academy Press, 1990, 163.Google Scholar
5.Institute of Medicine. Consensus development at the NIH: Improving the program. Washington, DC: National Academy Press, 1990, 81.Google Scholar
6.Kanouse, D. E., Brook, R. H., Winkler, J. D., et al. Changing medical practice through technology assessment: An evaluation of the National Institutes of Health consensus development program. Santa Monica, CA: The Rand Corp., 1989.Google Scholar
7.Mullan, F., & Jacoby, I.The town meeting for technology: The maturation of consensus conferences. Journal of the American Medical Association, 1985, 254, 1068–72.Google Scholar
8.National Institutes of Health. Bioelectric impedance analysis in body composition measurement. NIH Technology Assessment Statement, 12 12–14, 1994, 1–35.Google Scholar
9.National Institutes of Health. Bovine somatotropin: NIH Technology Assessment Conference statement on bovine somatotropin. Journal of the American Medical Association, 1991, 265, 1423–25.CrossRefGoogle Scholar
10.National Institutes of Health. Gaucher disease: Current issues in diagnosis and treatment: NIH Technology Assessment Panel on Gaucher Disease. Journal of the American Medical Association, 1996, 275, 548–53.CrossRefGoogle Scholar
11.National Institutes of Health. Guidelines for the planning and management of NIH Consensus Development Conferences. Bethesda, MD: National Institutes of Health, Office of the Director, Office of Medical Applications of Research, 1993.Google Scholar
12.National Institutes of Health. Guidelines for the selection and management of consensus development conferences. Bethesda, MD: National Institutes of Health, Office of the Director, Office of Medical Applications of Research, 1986.Google Scholar
13.National Institutes of Health. Guidelines for the selection and management of consensus development conferences. Bethesda, MD: National Institutes of Health, Office of the Director, Office of Medical Applications of Research, 1988.Google Scholar
14.National Institutes of Health. Methods for voluntary weight loss and control: NIH technology assessment conference panel. Annals of Internal Medicine, 1992, 116, 942–49.CrossRefGoogle Scholar
15.National Institutes of Health. Modeling in biomedical research: An assessment of current and potential approaches. NIH Technology Assessment Statement, 05 1–3, 1989.Google Scholar
16.National Institutes of Health. Ovarian cancer: Screening, treatment, and follow-up: NIH Consensus Development Panel on Ovarian Cancer. Journal of the American Medical Association, 1995, 273, 491–97.Google Scholar
17.National Institutes of Health. Statement: Effects and side-effects of dental restorative materials. Advances in Dental Research, 1992, 6, 139–44.Google Scholar
18.National Institutes of Health. The integration of behavioral and relaxation approaches into the treatment of chronic pain and insomna. NIH Technology Assessment Statement, 10 16–18, 1995.Google Scholar
19.National Institutes of Health. The Persian Gulf experience and health: NIH Technology Assessment Workshop Panel. Journal of the American Medical Association, 1994, 272, 391–96.Google Scholar
20.National Institutes of Health. Treatment of destructive behaviors in persons with developmental disabilities. NIH Consensus Statement, Sept 11–13, 1989, 7, 1–41.Google Scholar
21.National Institutes of Health. Treatment of early-stage breast cancer: NIH Consensus Development Panel on treatment of early-stage breast cancer. Journal of the American Medical Association, 1991, 265, 391–95.Google Scholar
22.Perry, S.The NIH Consensus Development Program: A decade later. New England Journal of Medicine, 1987, 317, 485–88.CrossRefGoogle Scholar
23.Perry, S., & Kalberer, J. T. Jr., The NIH Consensus Development Program and the assessment of health-care technologies: The first two years. New England Journal of Medicine, 1980, 303, 169–72.Google Scholar
24.Wortman, P.M., Vinokur, A., & Sechrest, L.Do consensus conferences work? A process evaluation of the NIH consensus development program. Journal of Health Politics, Policy and Law, 1988, 13, 469–97.Google Scholar